oritavancin

Known as: Chlorobiphenyl-chloroeremomycin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
010203020012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Oritavancin is a lipoglycopeptide with bactericidal activity against gram-positive bacteria. Its concentration… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
In this study, oritavancin had modal MIC, MIC50, and MIC90 values of 0.03, 0.03, and 0.06 μg/ml, respectively, against… (More)
Is this relevant?
2012
2012
Oritavancin is a semisynthetic lipoglycopeptide analogue of vancomycin that contains the heptapeptide core common to all… (More)
Is this relevant?
2009
2009
Slow-growing bacteria and biofilms are notoriously tolerant to antibiotics. Oritavancin is a lipoglycopeptide with multiple… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2009
2009
The increasing frequency of Enterococcus faecium isolates with multidrug resistance is a serious clinical problem given the… (More)
Is this relevant?
2008
2008
Solid-state NMR measurements performed on intact whole cells of Staphylococcus aureus labeled selectively in vivo have… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Oritavancin, a semisynthetic lipoglycopeptide with activity against gram-positive bacteria, has multiple mechanisms of action… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2008
2008
OBJECTIVES To compare the efficacy of oritavancin and vancomycin in the treatment of Clostridium difficile infection (CDI) using… (More)
Is this relevant?
2004
2004
The intracellular pharmacokinetics and pharmacodynamics of oritavancin (LY333328) were studied in cultured cells. Oritavancin was… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2003
2003
The pharmacokinetics and pharmacodynamics of oritavancin (LY333328), a glycopeptide antibiotic with concentration-dependent… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?